Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$766M |
| 2 |
Adobe
ADBE
|
$529M |
| 3 |
Merck
MRK
|
$463M |
| 4 |
Tesla
TSLA
|
$359M |
| 5 |
AGN
Allergan plc
AGN
|
$339M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$714M |
| 2 |
Gilead Sciences
GILD
|
$600M |
| 3 |
Perrigo
PRGO
|
$585M |
| 4 |
EMC
EMC CORPORATION
EMC
|
$448M |
| 5 |
Morgan Stanley
MS
|
$423M |
Sector Composition
| 1 | Healthcare | 17.95% |
| 2 | Consumer Discretionary | 15% |
| 3 | Communication Services | 10.58% |
| 4 | Technology | 9.94% |
| 5 | Financials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
Nordson
NDSN
$12.6B
| $2.27M | ﹤0.01% |
30,550
-8,047
| -21% | -$598K |
|
|
BCOV
552
DELISTED
Brightcove, Inc.
BCOV
| $2.23M | ﹤0.01% |
157,899
-3,173
| -2% | -$44.9K |
|
|
XLRN
553
DELISTED
Acceleron Pharma Inc.
XLRN
| $2.19M | ﹤0.01% |
+55,366
| New | +$2.19M |
|
|
SFG
554
DELISTED
STANCORP FINL GRP
SFG
| $2.12M | ﹤0.01% |
31,954
-40,199
| -56% | -$2.66M |
|
555
Manhattan Associates
MANH
$13B
| $2.11M | ﹤0.01% |
71,896
-916
| -1% | -$26.9K |
|
|
DST
556
DELISTED
DST Systems Inc.
DST
| $2.07M | ﹤0.01% |
45,598
-8,998
| -16% | -$408K |
|
557
Provident Financial Services
PFS
$2.61B
| $2.06M | ﹤0.01% |
106,654
+16,676
| +19% | +$322K |
|
|
BDBD
558
DELISTED
BOULDER BRANDS INC
BDBD
| $2.04M | ﹤0.01% |
128,372
-2,129
| -2% | -$33.8K |
|
|
GTIV
559
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
| $2.03M | ﹤0.01% |
163,555
-3,413
| -2% | -$42.4K |
|
560
Zions Bancorporation
ZION
$8.34B
| $2.03M | ﹤0.01% |
+67,629
| New | +$2.03M |
|
|
BCPC
561
Balchem Corporation
BCPC
$5.23B
| $2.01M | ﹤0.01% |
34,194
-6,563
| -16% | -$385K |
|
562
Glacier Bancorp
GBCI
$5.88B
| $1.97M | ﹤0.01% |
66,078
-148,169
| -69% | -$4.41M |
|
|
FNGN
563
DELISTED
Financial Engines, Inc.
FNGN
| $1.95M | ﹤0.01% |
28,085
+6,408
| +30% | +$445K |
|
564
Blackrock
BLK
$170B
| $1.91M | ﹤0.01% |
6,034
-4,871
| -45% | -$1.54M |
|
565
Foot Locker
FL
$2.29B
| $1.86M | ﹤0.01% |
44,977
-9,466
| -17% | -$392K |
|
566
TG Therapeutics
TGTX
$5.11B
| $1.78M | ﹤0.01% |
455,271
-1,083,831
| -70% | -$4.23M |
|
567
Bank of Hawaii
BOH
$2.72B
| $1.71M | ﹤0.01% |
28,990
-886
| -3% | -$52.4K |
|
568
United Therapeutics
UTHR
$18.1B
| $1.71M | ﹤0.01% |
15,087
-1,040
| -6% | -$118K |
|
569
ITT
ITT
$13.3B
| $1.69M | ﹤0.01% |
+38,878
| New | +$1.69M |
|
|
FMER
570
DELISTED
FIRSTMERIT CORP
FMER
| $1.68M | ﹤0.01% |
75,378
+16,457
| +28% | +$366K |
|
571
American States Water
AWR
$2.88B
| $1.67M | ﹤0.01% |
58,056
-1,774
| -3% | -$51K |
|
|
N
572
DELISTED
Netsuite Inc
N
| $1.66M | ﹤0.01% |
16,125
-400
| -2% | -$41.2K |
|
573
Plexus
PLXS
$3.75B
| $1.64M | ﹤0.01% |
37,970
+8,438
| +29% | +$365K |
|
|
ZQK
574
DELISTED
QUICKSILVER,INC.
ZQK
| $1.62M | ﹤0.01% |
184,970
-51,495
| -22% | -$452K |
|
575
Flushing Financial
FFIC
$457M
| $1.55M | ﹤0.01% |
74,783
-954
| -1% | -$19.7K |
|